The half-life of p21 mRNA increased after METTL3 knockdown (Fig. 4D, E) and decreased after METTL3 overexpression (Supplementary Fig. S4C, D), suggesting that METTL3 could decrease p21 mRNA stability in breast cancer cells. Here, CDKN1A is linked to breast carcinoma.